PDF - Presentation for Media & Analysts - Acino
PDF - Presentation for Media & Analysts - Acino
PDF - Presentation for Media & Analysts - Acino
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Acino</strong>’s in-licensing portfolio<br />
Status February 2013<br />
Under evaluation Under Signature Rights obtained<br />
Agreement signed<br />
Levofloxacine I.V.<br />
Antibiotic<br />
Moxilloxacine I.V.<br />
Antibiotic<br />
Dexibuprofen Oral<br />
Pain<br />
Tramadol/Paracetamol<br />
Combi Oral Pain<br />
Diclolenac Potassium<br />
Oral / Pain<br />
.<br />
7<br />
Pregabalin Oral<br />
Pain<br />
Telmisartan /<br />
Telmisartan HCL<br />
Oral / Pain<br />
Rosuvastatine Oral<br />
Statin<br />
1 3<br />
Esomeprazole I.V.<br />
Gastrointestinal<br />
Teicoplanin I.V.<br />
Antibiotic<br />
Anastrazole Oral<br />
Cancer<br />
Under registration<br />
EU / CH<br />
Paracetamol I.V.<br />
Pain<br />
Pantoprazole I.V.<br />
Gastrointestinal<br />
Zoledronic Acid I.V.<br />
Osteoperosis<br />
Levofloxacine Oral<br />
Antibiotic<br />
Legend:<br />
Celecoxib Oral<br />
Pain<br />
Total 18 projects Oral I.V.<br />
Ready <strong>for</strong> local<br />
submission<br />
5 2<br />
Zoledronic Acid I.V.<br />
Cancer<br />
Iron Sucrose I.V.<br />
Iron deficiency<br />
30
Change language